These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 17977517)

  • 21. LSD and phenethylamine hallucinogens: new structural analogy and implications for receptor geometry.
    Nichols DE; Pfister WR; Yim GK
    Life Sci; 1978 Jun; 22(24):2165-70. PubMed ID: 672453
    [No Abstract]   [Full Text] [Related]  

  • 22. Neurotransmitter basis of the behavioral effects of hallucinogens.
    Rech RH; Commissaris RL
    Neurosci Biobehav Rev; 1982; 6(4):521-7. PubMed ID: 6817241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.
    Blair JB; Kurrasch-Orbaugh D; Marona-Lewicka D; Cumbay MG; Watts VJ; Barker EL; Nichols DE
    J Med Chem; 2000 Nov; 43(24):4701-10. PubMed ID: 11101361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effects of LSD and lisuride: clues to specific hallucinogenic drug actions.
    White FJ
    Pharmacol Biochem Behav; 1986 Feb; 24(2):365-79. PubMed ID: 3952127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The identification of LSD-like hallucinogens using the chronic spinal dog.
    Martin WR; Vaupel DB; Nozaki M; Bright LD
    Drug Alcohol Depend; 1978 Mar; 3(2):113-23. PubMed ID: 272982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The intracranial injection of drug in goldfish. I: Hallucinogens and their antagonism to smooth muscle activity.
    Abramson HA; Gettner HH; Carone PA; Rolo A; Krinsky L
    J Asthma Res; 1979 Jan; 16(2):55-61. PubMed ID: 287665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
    Titeler M; Lyon RA; Glennon RA
    Psychopharmacology (Berl); 1988; 94(2):213-6. PubMed ID: 3127847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure activity relations of some indolealkylamines in comparison to phenethylamines on motor activity and acquisition of avoidance behavior.
    Vasko MR; Lutz MP; Domino EF
    Psychopharmacologia; 1974 Mar; 36(1):49-58. PubMed ID: 4525044
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemistry and Structure-Activity Relationships of Psychedelics.
    Nichols DE
    Curr Top Behav Neurosci; 2018; 36():1-43. PubMed ID: 28401524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic Similarities and Differences Among Hallucinogens.
    Waters K
    J Clin Pharmacol; 2021 Aug; 61 Suppl 2():S100-S113. PubMed ID: 34396556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress with several models for the study of the SAR of hallucinogenic agents.
    Kier LB; Glennon RA
    NIDA Res Monogr; 1978; (22):159-85. PubMed ID: 101879
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents.
    Glennon RA; Rosecrans JA; Young R
    Med Res Rev; 1983; 3(3):289-340. PubMed ID: 6350763
    [No Abstract]   [Full Text] [Related]  

  • 34. Dissociations between the effects of hallucinogens on behavior and raphe unit activity in behaving cats.
    Trulson ME
    Pharmacol Biochem Behav; 1986 Feb; 24(2):351-7. PubMed ID: 3952126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.
    Fantegrossi WE; Reissig CJ; Katz EB; Yarosh HL; Rice KC; Winter JC
    Pharmacol Biochem Behav; 2008 Jan; 88(3):358-65. PubMed ID: 17905422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Hallucinogens on Unconditioned Behavior.
    Halberstadt AL; Geyer MA
    Curr Top Behav Neurosci; 2018; 36():159-199. PubMed ID: 28224459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).
    Nichols DE; Frescas S; Marona-Lewicka D; Kurrasch-Orbaugh DM
    J Med Chem; 2002 Sep; 45(19):4344-9. PubMed ID: 12213075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hallucinogenic drugs are partial agonists of the human platelet shape change response: a physiological model of the 5-HT2 receptor.
    McClue SJ; Brazell C; Stahl SM
    Biol Psychiatry; 1989 Jul; 26(3):297-302. PubMed ID: 2742945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research.
    Vollenweider FX
    Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():92-103. PubMed ID: 9754840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mechanism of action of hallucinogenic drugs on a possible serotonin receptor in the brain.
    Smythies JR; Benington F; Morin RD
    Int Rev Neurobiol; 1970; 12():207-33. PubMed ID: 4918144
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.